Author

K. K. Hunt

Observed names: K. Hunt, K.K. Hunt

Institution: The University of Texas MD Anderson Cancer Center

Observed institution: The University of Texas MD Anderson Cancer Center

OpenAlex ID: A5126199735

Abstract PS4-12-26: Neosaci-io: neoadjuvant sacituzumab govitecan (sg) + pembrolizumab (pb) in patients (pts) with early-stage tnbc experiencing suboptimal response to keynote-522

2026 · C. Yam, T. Iwase, et al. · Clinical Cancer Research · 1

Abstract GS2-07: Effect of Preoperative Breast MRI Staging on Local Regional Recurrence (LRR) in Early Stage Breast cancer: Alliance A011104/ACRIN 6694

2026 · I. Bedrosian, K. Ballman, et al. · Clinical Cancer Research · 1

Abstract PD7-03: Circulating Immune Correlates of Pathological Response to Neoadjuvant Pembrolizumab plus Chemotherapy in High-Risk, Early-Stage Triple-Negative Breast Cancer

2026 · C. Yam, A. Radko, et al. · Clinical Cancer Research

Abstract RF1-02: Surgical outcomes in the ALTERNATE trial (Alliance A011106) -a randomized phase 3 neoadjuvant endocrine therapy (NET) trial in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC)

2026 · A. M. Leitch, T. Dockter, et al. · Clinical Cancer Research

Prospective Single-Arm Trial of Preoperative 42.75 Gy in 15 Fractions for Soft Tissue Sarcoma of the Extremity/Trunk

2022 · B.A. Guadagnolo, D. Mitra, et al. · International Journal of Radiation Oncology*Biology*Physics

1493MO Peripheral immune biomarkers of survival in patients with resectable dedifferentiated liposarcomas (DDLPS) and undifferentiated pleomorphic sarcomas (UPS) treated with neoadjuvant nivolumab +/- ipilimumab (neoICB)

2022 · E.F. Nassif, E.Z. Keung, et al. · Annals of Oncology

2007 · E.A. Mittendorf, T. McKenzie-Johnson, et al. · Journal of Surgical Research

Works count: 7

Citation count: 2

H-index: 1

I10-index: